학술논문
A modified HSV-1 oncolytic virus reconciles antiviral and antitumor immunity via promoting IFNβ expression and inhibiting PKR
Document Type
Article
Author
Source
In International Journal of Biological Macromolecules August 2024 274 Part 2
Subject
Language
ISSN
0141-8130